Clinical outcome of helical tomotherapy for inoperable non-small cell lung cancer: The Kyung Hee University Medical Center experience

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 4, 2014, Pages 1545-1549

  Kong, Moonkyoo ^a   Hong, Seong Eon ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

Clinical outcome; Helical tomotherapy; Korea; Lung cancer

Indexed keywords

AGED; ARTICLE; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SOUTH KOREA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, INTENSITY-MODULATED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84897007955     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.4.1545     Document Type: Article

References (27)

1. Bradley J, Graham MV, Winter K, et al (2005). Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys, 61, 318-28.
2. Brenner DJ, Doll R, Goodhead DT, et al (2003). Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA, 100, 13761-6.
3. Cattaneo GM, Dell'oca I, Broggi S, et al (2008). Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC. Radiother Oncol, 88, 310-8.
4. Chang JY, Liu HH, Komaki R (2005). Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer. Curr Oncol Rep, 7, 255-9.
5. Christian JA, Bedford JL, Webb S, Brada M (2007). Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 67, 735-41.
6. Ding XP, Zhang J, Li BS, et al (2012). Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers. Asian Pac J Cancer Prev, 13, 319-23.
7. Gopal R, Tucker SL, Komaki R, et al (2003). The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys, 56, 106-13.
8. Govaert SL, Troost EG, Schuurbiers OC, et al (2012). Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients. Radiat Oncol, 7, 150.
9. Grills IS, Yan D, Martinez AA, et al (2003). Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys, 57, 875-90.
10. Hall EJ (2006). Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys, 65, 1-7.
11. Jiang ZQ, Yang K, Komaki R, et al (2012). Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. Int J Radiat Oncol Biol Phys, 83, 332-9.
12. Kron T, Grigorov G, Yu E, et al (2004). Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy. Phys Med Biol, 49, 3675-90.
13. Lee JH, Wu HG, Kim HJ, et al (2013). Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer. Radiat Oncol J, 31, 18-24.
14. Liao ZX, Komaki RR, Thames HD Jr, et al (2010). Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys, 76, 775-81.
15. Liu HH, Wang X, Dong L, et al (2004). Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 58, 1268-79.
16. Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5.
17. Mackie TR, Holmes T, Swerdloff S, et al (1993). Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys, 20, 1709-19.
18. Mehta M, Scrimger R, Mackie R, et al (2001). A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 49, 23-33.
19. Murshed H, Liu HH, Liao Z, et al (2004). Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 58, 1258-67.
20. Rengan R, Rosenzweig KE, Venkatraman E, et al (2004). Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 60, 741-7.
21. Rosenzweig KE, Fox JL, Yorke E, et al (2005). Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer, 103, 2118-27.
22. Schwarz M, Alber M, Lebesque JV, Mijnheer BJ, Damen EM (2005). Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 62, 561-70.
23. Scrimger RA, Tome WA, Olivera GH, et al (2003). Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements. Am J Clin Oncol, 26, 70-8.
24. Sura S, Gupta V, Yorke E, et al (2008). Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol, 87, 17-23.
25. Wu VW, Kwong DL,Sham JS (2004). Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol, 71, 201-6.
26. Yom SS, Liao Z, Liu HH, et al (2007). Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys, 68, 94-102.
27. Zheng DJ, Yu GH, Gao JF, Gu JD (2013). Concomitant EGFR inhibitors combined with radiation for treatment of non-small cell lung carcinoma. Asian Pac J Cancer Prev, 14, 4485-94.